- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04876274
Social Media-Delivered Patient Education in Enhancing Type 2 Diabetics Self-Management and Attitudes During the COVID-19 Pandemic
Social Media-Delivered Patient Education in Enhancing Type 2 Diabetics Self-Management and Attitudes During the COVID-19 Pandemic: a Randomized Controlled Trial in Taiwan
The current study was to develop a software "Line@" based health education program, providing video-based health information and communication between diabetes patients and health-care professionals. This study also evaluated its effectiveness on improving glycemic control, attitude towards diabetes, knowledge about diabetes and self-care for type 2 diabetes patients in Taiwan.
The followings were the hypotheses of the study:
- Compared to the control group, intervention group receiving "Line" based video education has a greater improvement on glycosylated hemoglobin (A1C).
- Compared to the control group, intervention group receiving "Line" based video education has a greater positive effect on attitude towards diabetes.
- Compared to the control group, intervention group receiving "Line" based video education has a better understanding on diabetic knowledge.
- Compared to the control group, intervention group receiving "Line" based video education has a greater positive effect on self-care activity.
Study Overview
Detailed Description
The study was conducted in the Endocrinology and Metabolism Clinic in Taipei Medical University Wang-Fang Hospital. Patients were referred from physicians if they met the inclusion criteria and consent to join. Written consent and questionnaires were then provided to the participants after researcher had clearly explained the study purpose.
Based on the seven key points in managing diabetes developed by the association of diabetes care and education specialist (ADCES), including healthy coping, healthy eating, being active, monitoring, taking medication, problem solving and reducing risks, the research team had developed 51 diabetes related health educational videos (available at website of School of Pharmacy, Taipei Medical University http://pharmschool.tmu.edu.tw/activity/index.php?type=20). Each video lasted for about 2-3 minutes. According to the content of the videos, it was categorized into 5 domains, including understanding diabetes, daily care, nutrition care, diabetes drug and diabetes knowledge related quizzes.
Patients in intervention group could attend the video through the line platform. Researcher would also send 2-3 videos per week with care massage every 2 weeks to the patients. The general schedule of video was shown in table x. According to various condition, researcher developed specific video schedule for each patients. For example, patient who was prescribed with A drug, we would only send the video regarding A drug to this patient but not all of the video regarding drugs. Schedule for the part of understanding diabetes, daily care, nutrition care and quizzes was the same among all participants. Due to the quizzes that were put in week 3, 6, 9 and 12, videos related to general knowledge about diabetes would be send to patients first to make sure all the quizzes related content had already taught to patients before the quizzes. Moreover, patients could communicate with the research team and ask questions through the platform, researcher would provide answers verified by pharmacists or physicians in one or two days after.
The sample size of this study was estimated using G-power (version 3.1). Assuming a power of 80% with two-sided alpha level for detecting the difference between the intervention group and the control group, at least 64 patients were needed for each group. Considering 20% dropout rate, the study was designed to have at least 80 patients for each group, 160 patients in total.
Patients were randomized in a 1:1 ratio according to the random allocation sequence generated prior to the study. Patients with odd number were allocated into control group while even numbers were allocated into intervention group. The trial was non-blinded because of its feasibility.
Researcher would not provide any inductive explanation to the patient during filling the questionnaire. If patient had questions about the items, a detailed explanation and health education were provided only after finishing the post-test. The returned questionnaires were collected by the researcher and kept in the Department of Clinical Pharmacy, School of Pharmacy, Taipei Medical University for three years.
All the data were analyzed using SPSS (SPSS Inc. Released 2009. Predictive Analytics Suite Workstation (PASW) Statistics for Windows, Version 18.0. Chicago: SPSS Inc.). A two-tailed p value of 0.05 was considered to be statistically significant in the analysis. For personal characteristics, descriptive analysis was performed. According to the characteristic of data, Chi-square test and t-test was used for detecting the differences between groups. a Wilcoxon signed rank test or paired t-tests was performed for the differences in A1C and the scores between pre and post-test about knowledge, self-care activity and attitude towards diabetes. A Mann-Whitney test or unpaired t-tests was performed for the mean differences between control and intervention group. Logistics regression was performed for the correlation between variables.
Patients who had finished both pre- and post-assessment would be included for analysis, those without post-test would be excluded. Missing values were processed by multiple imputation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan
- School of Pharmacy, Taipei Medical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Type 2 Diabetes mellitus (T2DM)
- Age 20 or older
- Had at least 1 A1C data in the past 6 months
- Possessed a smart-cellphone
- A1C ≥ 6%
Exclusion Criteria:
- Gestational diabetes
- Cognitive impairment
- No medication treatment but dietary control alone
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Patients in the intervention group received Taipei Medical University (TMU) line-oriented video education and care in addition to usual care
|
Patients in intervention group could attend diabetes-related health educational video through the TMU-LOVE platform.
Researcher would also send 2-3 videos per week with care massage every 2 weeks to the patients.
|
No Intervention: Control group
Patients in the control group received usual care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HbA1C
Time Frame: 12 weeks
|
Improvement in glycemic control
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Score of Diabetes Care Profile-Attitudes Toward Diabetes Scales
Time Frame: 12 weeks
|
The Chinese version of Diabetes Care Profile-Attitudes Toward Diabetes Scales (DCP-ATDS) was used for measuring patients' attitude towards diabetes at baseline and 12 weeks.
Each item was rated on a five-point Likert scale, the total score was in the range of 23-115, in which higher scores mean patient had better attitudes towards diabetes.
|
12 weeks
|
Score of Summary of Diabetes Self-Care Activities
Time Frame: 12 weeks
|
The Chinese version of Summary of Diabetes Self-Care Activities (SDSCA) was used for measuring patients' self-care activities at baseline and 12 weeks.
Each item was rated from 0 to 7. For patients who were prescribed with either oral medication or insulin injection, the total score ranged from 0 to 63.
The total score for patients who were taking both oral and insulin medications ranged from 0 to 70.
The mean scores were calculated separately according to the total score ranges.
A higher scores mean better self-care behavior.
|
12 weeks
|
Score of Simplified True / False Version of Diabetes Knowledge Scale
Time Frame: 12 weeks
|
The Chinese version of Simplified true/false version of revised Diabetes Knowledge Scale (SDKS) was used for measuring patients' knowledge about diabetes at baseline and 12 weeks.
A score of "1" was given if the patient responded with the correct answer and "0" was given for incorrect answer or answered with "Don't know".
For patients who were prescribed with insulin treatment, the total score ranged from 0 to 24, for those without insulin treatment, the total score ranged from 0 to 22.
The mean scores were calculated separately according to the total score ranges.
A higher score indicated higher level of knowledge about diabetes.
|
12 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Score of Newest Vital Sign
Time Frame: 12 weeks
|
The Chinese version of Newest Vital Sign (NVS) was used for measuring patients' health literacy level.
A score of "1" was given if the patient responded with the correct answer and "0" was given for incorrect answer.
The total score ranged from 0 to 6, with higher scores mean better health literacy level.
|
12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Chen Hsiang-Yin, Pharm.D., Professor and Associate Dean, College of Pharmacy, Taipei Medical University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Glucose Metabolism Disorders
- Metabolic Diseases
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- RNA Virus Infections
- Virus Diseases
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Pneumonia, Viral
- Pneumonia
- Lung Diseases
- Endocrine System Diseases
- Diabetes Mellitus
- COVID-19
- Diabetes Mellitus, Type 2
Other Study ID Numbers
- TMU-LOVE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
Clinical Trials on TMU-LOVE
-
Centers for Disease Control and PreventionSisterLove, Inc.CompletedHIV Infections | Sexually Transmitted InfectionsUnited States
-
Franciscus GasthuisChiesi Farmaceutici S.p.A.; Revenio Research; Stichting BeterKetenRecruitingSmoking Cessation | Respiratory Tract Infections | Premature Birth | Preterm Birth | Telemedicine | Bronchopulmonary Dysplasia | Respiratory Disease | RSV Infection | Pollution; Exposure | Health-Related Behavior | eHealth | Bronchial Hyperreactivity | Pollution Related Respiratory Disorder | RSV PneumoniaNetherlands
-
Northeastern UniversityNational Institute of Nursing Research (NINR)CompletedRisk Behavior | HIV | Sexual Behavior | Chlamydia | Women's RoleUnited States
-
University of California, Los AngelesUniversity of North Carolina, Chapel Hill; University of California, Irvine; Florida... and other collaboratorsRecruitingHIV InfectionsUnited States
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA)Recruiting
-
University of Texas at AustinActive, not recruiting
-
University of Miami Sylvester Comprehensive Cancer...The V Foundation for Cancer ResearchRecruitingObesity | Diet, Healthy | Cancer, Breast | Activity, Motor | Cancer, Uterus | Cancer, OvaryUnited States
-
York UniversityMcMaster University; University of TorontoActive, not recruitingMarital Relationship | Family Conflict | Internet-Based Intervention | Interparental Conflict | Marital ConflictCanada
-
Lawson Health Research InstituteWestern University, CanadaRecruiting
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteCompletedHIV InfectionsUnited States